BGT — Bio-Gene Technology Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$15.10m
- AU$11.88m
- AU$0.68m
- 42
- 12
- 24
- 15
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.145 | 0.183 | 0.129 | 0.054 | 0.086 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.2 | -1.64 | -1.83 | -1.99 | -3.28 |
Capital Expenditures | -0.003 | 0 | -0.003 | -0.007 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.004 | 0 | 0 | 0 | 0 |
Purchase of Investments | |||||
Cash from Investing Activities | -0.007 | 0 | -0.003 | -0.007 | 0 |
Financing Cash Flow Items | 0 | -0.148 | -0.021 | -0.236 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.001 | 2.67 | 0.24 | 4.41 | -0.075 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.21 | 1.02 | -1.59 | 2.41 | -3.35 |